Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
23 Ergebnisse
| MG06K7 |  | Alnylam Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 222,770 | 222,770 | 4,747 | 22,304 % | - | Morgan Stanley | |
| MG2XFZ | | Alnylam Pharmaceuticals Inc./Faktor/Long [6]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 232,053 | 232,053 | 5,835 | 19,067 % | - | Morgan Stanley | |
| MG6A5H | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 143,089 | 168,580 | 2,024 | 41,204 % | - | Morgan Stanley | |
| MG6WDN | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 162,906 | 191,930 | 2,384 | 33,060 % | - | Morgan Stanley | |
| MG6X19 | | Alnylam Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 208,847 | 208,847 | 3,775 | 27,160 % | - | Morgan Stanley | |
| MG6X1A | | Alnylam Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 222,770 | 222,770 | 4,900 | 22,304 % | - | Morgan Stanley | |
| MG6X76 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 180,215 | 180,215 | 2,765 | 37,146 % | - | Morgan Stanley | |
| MG6X78 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 204,244 | 204,244 | 3,589 | 28,765 % | - | Morgan Stanley | |
| MG783L | | Alnylam Pharmaceuticals Inc./Faktor/Long [3]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 185,642 | 185,642 | 2,876 | 35,253 % | - | Morgan Stanley | |
| MJ6XU3 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 194,784 | 229,490 | 3,218 | 19,960 % | - | Morgan Stanley | |
| MK17QY | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 153,169 | 180,460 | 2,183 | 37,061 % | - | Morgan Stanley | |
| MK5DGN | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 245,124 | 245,124 | - | 14,507 % | - | Morgan Stanley | |
| MK6NK1 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 232,838 | 232,838 | 5,500 | 18,793 % | - | Morgan Stanley | |
| MK95AW | | Alnylam Pharmaceuticals Inc./Faktor/Short [2]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 417,590 | 417,590 | 2,104 | 45,644 % | - | Morgan Stanley | |
| MK95AX | | Alnylam Pharmaceuticals Inc./Faktor/Short [4]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 347,992 | 347,992 | 4,326 | 21,370 % | - | Morgan Stanley | |
| MM1MQQ | | Alnylam Pharmaceuticals Inc./Faktor/Short [5]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 334,072 | 334,072 | 5,503 | 16,515 % | - | Morgan Stanley | |
| MM1MV5 | | Alnylam Pharmaceuticals Inc./Faktor/Long [2]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 139,232 | 139,232 | 1,955 | 51,440 % | - | Morgan Stanley | |
| MM20JL | | Alnylam Pharmaceuticals Inc./Faktor/Short [3]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 371,191 | 371,191 | 3,197 | 29,461 % | - | Morgan Stanley | |
| MN11W8 | | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 398,123 | 398,123 | 2,368 | 38,854 % | - | Morgan Stanley | |
| MN9KUT | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 215,520 | 253,920 | 4,199 | 11,440 % | - | Morgan Stanley | |
| MR1XNL | | Alnylam Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 208,847 | 208,847 | - | 27,160 % | - | Morgan Stanley | |
| MR426K | | Alnylam Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 222,770 | 222,770 | - | 22,304 % | - | Morgan Stanley | |
| MR4DLF | | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 299,957 | 299,957 | - | 4,617 % | - | Morgan Stanley |